Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 87 entries
Sorted by: Best Match Show Resources per page
Error propagation in the characterization of atheromatic plaque types based on imaging.

Computer methods and programs in biomedicine

Athanasiou LS, Rigas G, Sakellarios A, Bourantas CV, Stefanou K, Fotiou E, Exarchos TP, Siogkas P, Naka KK, Parodi O, Vozzi F, Teng Z, Young VE, Gillard JH, Prati F, Michalis LK, Fotiadis DI.
PMID: 26165637
Comput Methods Programs Biomed. 2015 Oct;121(3):161-74. doi: 10.1016/j.cmpb.2015.06.002. Epub 2015 Jul 02.

Imaging systems transmit and acquire signals and are subject to errors including: error sources, signal variations or possible calibration errors. These errors are included in all imaging systems for atherosclerosis and are propagated to methodologies implemented for the segmentation...

Cite
Athanasiou LS, Rigas G, Sakellarios A, et al. Error propagation in the characterization of atheromatic plaque types based on imaging. Comput Methods Programs Biomed. 2015;121(3):161-74doi: 10.1016/j.cmpb.2015.06.002.
Athanasiou, L. S., Rigas, G., Sakellarios, A., Bourantas, C. V., Stefanou, K., Fotiou, E., Exarchos, T. P., Siogkas, P., Naka, K. K., Parodi, O., Vozzi, F., Teng, Z., Young, V. E., Gillard, J. H., Prati, F., Michalis, L. K., & Fotiadis, D. I. (2015). Error propagation in the characterization of atheromatic plaque types based on imaging. Computer methods and programs in biomedicine, 121(3), 161-74. https://doi.org/10.1016/j.cmpb.2015.06.002
Athanasiou, Lambros S, et al. "Error propagation in the characterization of atheromatic plaque types based on imaging." Computer methods and programs in biomedicine vol. 121,3 (2015): 161-74. doi: https://doi.org/10.1016/j.cmpb.2015.06.002
Athanasiou LS, Rigas G, Sakellarios A, Bourantas CV, Stefanou K, Fotiou E, Exarchos TP, Siogkas P, Naka KK, Parodi O, Vozzi F, Teng Z, Young VE, Gillard JH, Prati F, Michalis LK, Fotiadis DI. Error propagation in the characterization of atheromatic plaque types based on imaging. Comput Methods Programs Biomed. 2015 Oct;121(3):161-74. doi: 10.1016/j.cmpb.2015.06.002. Epub 2015 Jul 02. PMID: 26165637.
Copy Download .nbib Format: NLM
Deep Vein Thrombosis: Final Report of the Prospective Multicenter Pearl Registry on Endovascular Treatment.

Journal of vascular surgery. Venous and lymphatic disorders

Amin A, Blitz L, Garcia M, Lookstein R, Simoni E, Soukas P.
PMID: 26992993
J Vasc Surg Venous Lymphat Disord. 2014 Jan;2(1):108. doi: 10.1016/j.jvsv.2013.10.015. Epub 2013 Dec 12.

No abstract available.

Cite
Amin A, Blitz L, Garcia M, et al. Deep Vein Thrombosis: Final Report of the Prospective Multicenter Pearl Registry on Endovascular Treatment. J Vasc Surg Venous Lymphat Disord. 2013;2(1):108doi: 10.1016/j.jvsv.2013.10.015.
Amin, A., Blitz, L., Garcia, M., Lookstein, R., Simoni, E., & Soukas, P. (2014). Deep Vein Thrombosis: Final Report of the Prospective Multicenter Pearl Registry on Endovascular Treatment. Journal of vascular surgery. Venous and lymphatic disorders, 2(1), 108. https://doi.org/10.1016/j.jvsv.2013.10.015
Amin, A, et al. "Deep Vein Thrombosis: Final Report of the Prospective Multicenter Pearl Registry on Endovascular Treatment." Journal of vascular surgery. Venous and lymphatic disorders vol. 2,1 (2014): 108. doi: https://doi.org/10.1016/j.jvsv.2013.10.015
Amin A, Blitz L, Garcia M, Lookstein R, Simoni E, Soukas P. Deep Vein Thrombosis: Final Report of the Prospective Multicenter Pearl Registry on Endovascular Treatment. J Vasc Surg Venous Lymphat Disord. 2014 Jan;2(1):108. doi: 10.1016/j.jvsv.2013.10.015. Epub 2013 Dec 12. PMID: 26992993.
Copy Download .nbib Format: NLM
Usefulness of Renal Arteriography Following Coronary Angiography.

The Journal of invasive cardiology

Siogas C, Goudevenos J, Pappas S, Foussas S, Graekas G, Siamopoulos K, Sideris D.
PMID: 10785710
J Invasive Cardiol. 1996 Jun;8(5):223-227.

PURPOSE: To determine the usefulness of renal angiography in patients that underwent coronary angiography because of clinically suspected coronary artery disease. METHODS: Selective arteriography of the renal arteries was performed in 205 patients (mean age 60 +/- 8 years;...

Cite
Siogas C, Goudevenos J, Pappas S, et al. Usefulness of Renal Arteriography Following Coronary Angiography. J Invasive Cardiol. 1996;8(5):223-227
Siogas, C., Goudevenos, J., Pappas, S., Foussas, S., Graekas, G., Siamopoulos, K., & Sideris, D. (1996). Usefulness of Renal Arteriography Following Coronary Angiography. The Journal of invasive cardiology, 8(5), 223-227.
Siogas, et al. "Usefulness of Renal Arteriography Following Coronary Angiography." The Journal of invasive cardiology vol. 8,5 (1996): 223-227.
Siogas C, Goudevenos J, Pappas S, Foussas S, Graekas G, Siamopoulos K, Sideris D. Usefulness of Renal Arteriography Following Coronary Angiography. J Invasive Cardiol. 1996 Jun;8(5):223-227. PMID: 10785710.
Copy Download .nbib Format: NLM
Progressive Immunodeficiency with Gradual Depletion of B and CD4⁺ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2).

Diseases (Basel, Switzerland)

Sogkas G, Dubrowinskaja N, Bergmann AK, Lentes J, Ripperger T, Fedchenko M, Ernst D, Jablonka A, Geffers R, Baumann U, Schmidt RE, Atschekzei F.
PMID: 30987377
Diseases. 2019 Apr 04;7(2). doi: 10.3390/diseases7020034.

Immunodeficiency, centromeric instability and facial anomalies syndrome 2 (ICF2) is a rare autosomal recessive primary immunodeficiency disorder. So far, 27 patients have been reported. Here, we present three siblings with ICF2 due to a homozygous ZBTB24 gene mutation (c.1222...

Cite
Sogkas G, Dubrowinskaja N, Bergmann AK, et al. Progressive Immunodeficiency with Gradual Depletion of B and CD4⁺ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2). Diseases. 2019;7(2)doi: 10.3390/diseases7020034.
Sogkas, G., Dubrowinskaja, N., Bergmann, A. K., Lentes, J., Ripperger, T., Fedchenko, M., Ernst, D., Jablonka, A., Geffers, R., Baumann, U., Schmidt, R. E., & Atschekzei, F. (2019). Progressive Immunodeficiency with Gradual Depletion of B and CD4⁺ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2). Diseases (Basel, Switzerland), 7(2), . https://doi.org/10.3390/diseases7020034
Sogkas, Georgios, et al. "Progressive Immunodeficiency with Gradual Depletion of B and CD4⁺ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2)." Diseases (Basel, Switzerland) vol. 7,2 (2019). doi: https://doi.org/10.3390/diseases7020034
Sogkas G, Dubrowinskaja N, Bergmann AK, Lentes J, Ripperger T, Fedchenko M, Ernst D, Jablonka A, Geffers R, Baumann U, Schmidt RE, Atschekzei F. Progressive Immunodeficiency with Gradual Depletion of B and CD4⁺ T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2). Diseases. 2019 Apr 04;7(2). doi: 10.3390/diseases7020034. PMID: 30987377; PMCID: PMC6631482.
Copy Download .nbib Format: NLM
Corrigendum to: The Beneficial Effects of Computer-Based Cognitive Training in Parkinson's Disease: A Systematic Review.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists

Nousia A, Martzoukou M, Tsouris Z, Siokas V, Aloizou AM, Liampas I, Nasios G, Dardiotis E.
PMID: 32706365
Arch Clin Neuropsychol. 2021 Jan 15;36(1):149. doi: 10.1093/arclin/acaa054.

No abstract available.

Cite
Nousia A, Martzoukou M, Tsouris Z, et al. Corrigendum to: The Beneficial Effects of Computer-Based Cognitive Training in Parkinson's Disease: A Systematic Review. Arch Clin Neuropsychol. 2021;36(1):149doi: 10.1093/arclin/acaa054.
Nousia, A., Martzoukou, M., Tsouris, Z., Siokas, V., Aloizou, A. M., Liampas, I., Nasios, G., & Dardiotis, E. (2021). Corrigendum to: The Beneficial Effects of Computer-Based Cognitive Training in Parkinson's Disease: A Systematic Review. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 36(1), 149. https://doi.org/10.1093/arclin/acaa054
Nousia, Anastasia, et al. "Corrigendum to: The Beneficial Effects of Computer-Based Cognitive Training in Parkinson's Disease: A Systematic Review." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists vol. 36,1 (2021): 149. doi: https://doi.org/10.1093/arclin/acaa054
Nousia A, Martzoukou M, Tsouris Z, Siokas V, Aloizou AM, Liampas I, Nasios G, Dardiotis E. Corrigendum to: The Beneficial Effects of Computer-Based Cognitive Training in Parkinson's Disease: A Systematic Review. Arch Clin Neuropsychol. 2021 Jan 15;36(1):149. doi: 10.1093/arclin/acaa054. PMID: 32706365.
Copy Download .nbib Format: NLM
Migraine in transient global amnesia: a meta-analysis of observational studies.

Journal of neurology

Liampas I, Siouras AS, Siokas V, Tsouris Z, Rikos D, Brotis A, Aloizou AM, Dastamani M, Dardiotis E.
PMID: 33388926
J Neurol. 2022 Jan;269(1):184-196. doi: 10.1007/s00415-020-10363-y. Epub 2021 Jan 02.

BACKGROUND: PURPOSE: Although many studies have investigated the relationship between transient global amnesia (TGA) and migraine, to date, no meta-analysis has confirmed the existence and size of their association.METHODOLOGY: Literature search involved MEDLINE, EMBASE, CENTRAL and PsycINFO. Observational controlled...

Cite
Liampas I, Siouras AS, Siokas V, et al. Migraine in transient global amnesia: a meta-analysis of observational studies. J Neurol. 2021;269(1):184-196doi: 10.1007/s00415-020-10363-y.
Liampas, I., Siouras, A. S., Siokas, V., Tsouris, Z., Rikos, D., Brotis, A., Aloizou, A. M., Dastamani, M., & Dardiotis, E. (2022). Migraine in transient global amnesia: a meta-analysis of observational studies. Journal of neurology, 269(1), 184-196. https://doi.org/10.1007/s00415-020-10363-y
Liampas, Ioannis, et al. "Migraine in transient global amnesia: a meta-analysis of observational studies." Journal of neurology vol. 269,1 (2022): 184-196. doi: https://doi.org/10.1007/s00415-020-10363-y
Liampas I, Siouras AS, Siokas V, Tsouris Z, Rikos D, Brotis A, Aloizou AM, Dastamani M, Dardiotis E. Migraine in transient global amnesia: a meta-analysis of observational studies. J Neurol. 2022 Jan;269(1):184-196. doi: 10.1007/s00415-020-10363-y. Epub 2021 Jan 02. PMID: 33388926.
Copy Download .nbib Format: NLM
A proof-of-concept study for the prediction of the de-novo atherosclerotic plaque development using finite elements.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Sakellarios AI, Tsompou P, Kigka V, Karanasiou G, Tsarapatsani K, Kyriakidis S, Karanasiou G, Siogkas P, Nikopoulos S, Rocchiccioli S, Pelosi G, Michalis LK, Fotiadis DI.
PMID: 34892184
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:4354-4357. doi: 10.1109/EMBC46164.2021.9629792.

The type of the atherosclerotic plaque has significant clinical meaning since plaque vulnerability depends on its type. In this work, we present a computational approach which predicts the development of new plaques in coronary arteries. More specifically, we employ...

Cite
Sakellarios AI, Tsompou P, Kigka V, et al. A proof-of-concept study for the prediction of the de-novo atherosclerotic plaque development using finite elements. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:4354-4357doi: 10.1109/EMBC46164.2021.9629792.
Sakellarios, A. I., Tsompou, P., Kigka, V., Karanasiou, G., Tsarapatsani, K., Kyriakidis, S., Karanasiou, G., Siogkas, P., Nikopoulos, S., Rocchiccioli, S., Pelosi, G., Michalis, L. K., & Fotiadis, D. I. (2021). A proof-of-concept study for the prediction of the de-novo atherosclerotic plaque development using finite elements. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 20214354-4357. https://doi.org/10.1109/EMBC46164.2021.9629792
Sakellarios, Antonis I, et al. "A proof-of-concept study for the prediction of the de-novo atherosclerotic plaque development using finite elements." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2021 (2021): 4354-4357. doi: https://doi.org/10.1109/EMBC46164.2021.9629792
Sakellarios AI, Tsompou P, Kigka V, Karanasiou G, Tsarapatsani K, Kyriakidis S, Karanasiou G, Siogkas P, Nikopoulos S, Rocchiccioli S, Pelosi G, Michalis LK, Fotiadis DI. A proof-of-concept study for the prediction of the de-novo atherosclerotic plaque development using finite elements. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:4354-4357. doi: 10.1109/EMBC46164.2021.9629792. PMID: 34892184.
Copy Download .nbib Format: NLM
Therapeutic Application of rTMS in Atypical Parkinsonian Disorders.

Behavioural neurology

Petsani C, Aloizou AM, Siokas V, Messinis L, Peristeri E, Bakirtzis C, Nasios G, Dardiotis E.
PMID: 34976231
Behav Neurol. 2021 Dec 23;2021:3419907. doi: 10.1155/2021/3419907. eCollection 2021.

The terms atypical parkinsonian disorders (APDs) and Parkinson plus syndromes are mainly used to describe the four major entities of sporadic neuronal multisystem degeneration: progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and dementia with Lewy...

Cite
Petsani C, Aloizou AM, Siokas V, et al. Therapeutic Application of rTMS in Atypical Parkinsonian Disorders. Behav Neurol. 2021;2021:3419907doi: 10.1155/2021/3419907.
Petsani, C., Aloizou, A. M., Siokas, V., Messinis, L., Peristeri, E., Bakirtzis, C., Nasios, G., & Dardiotis, E. (2021). Therapeutic Application of rTMS in Atypical Parkinsonian Disorders. Behavioural neurology, 20213419907. https://doi.org/10.1155/2021/3419907
Petsani, Chrysi, et al. "Therapeutic Application of rTMS in Atypical Parkinsonian Disorders." Behavioural neurology vol. 2021 (2021): 3419907. doi: https://doi.org/10.1155/2021/3419907
Petsani C, Aloizou AM, Siokas V, Messinis L, Peristeri E, Bakirtzis C, Nasios G, Dardiotis E. Therapeutic Application of rTMS in Atypical Parkinsonian Disorders. Behav Neurol. 2021 Dec 23;2021:3419907. doi: 10.1155/2021/3419907. eCollection 2021. PMID: 34976231; PMCID: PMC8718319.
Copy Download .nbib Format: NLM
Therapeutic options for CTLA-4 insufficiency.

The Journal of allergy and clinical immunology

Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králíčková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD, Grimbacher B.
PMID: 34111452
J Allergy Clin Immunol. 2021 Jun 07; doi: 10.1016/j.jaci.2021.04.039. Epub 2021 Jun 07.

BACKGROUND: Heterozygous germline mutations in cytotoxic T lymphocyte-associated antigen-4 (CTLA4) impair the immunomodulatory function of regulatory T cells. Affected individuals are prone to life-threatening autoimmune and lymphoproliferative complications. A number of therapeutic options are currently being used with variable...

Cite
Egg D, Rump IC, Mitsuiki N, et al. Therapeutic options for CTLA-4 insufficiency. J Allergy Clin Immunol. 2021;doi: 10.1016/j.jaci.2021.04.039.
Egg, D., Rump, I. C., Mitsuiki, N., Rojas-Restrepo, J., Maccari, M. E., Schwab, C., Gabrysch, A., Warnatz, K., Goldacker, S., Patiño, V., Wolff, D., Okada, S., Hayakawa, S., Shikama, Y., Kanda, K., Imai, K., Sotomatsu, M., Kuwashima, M., Kamiya, T., Morio, T., Matsumoto, K., Mori, T., Yoshimoto, Y., Dybedal, I., Kanariou, M., Kucuk, Z. Y., Chapdelaine, H., Petruzelkova, L., Lorenz, H. M., Sullivan, K. E., Heimall, J., Moutschen, M., Litzman, J., Recher, M., Albert, M. H., Hauck, F., Seneviratne, S., Pachlopnik Schmid, J., Kolios, A., Unglik, G., Klemann, C., Snapper, S., Giulino-Roth, L., Svaton, M., Platt, C. D., Hambleton, S., Neth, O., Gosse, G., Reinsch, S., Holzinger, D., Kim, Y. J., Bakhtiar, S., Atschekzei, F., Schmidt, R., Sogkas, G., Chandrakasan, S., Rae, W., Derfalvi, B., Marquart, H. V., Ozen, A., Kiykim, A., Karakoc-Aydiner, E., Králíčková, P., de Bree, G., Kiritsi, D., Seidel, M. G., Kobbe, R., Dantzer, J., Alsina, L., Armangue, T., Lougaris, V., Agyeman, P., Nyström, S., Buchbinder, D., Arkwright, P. D., & Grimbacher, B. (2021). Therapeutic options for CTLA-4 insufficiency. The Journal of allergy and clinical immunology, . https://doi.org/10.1016/j.jaci.2021.04.039
Egg, David, et al. "Therapeutic options for CTLA-4 insufficiency." The Journal of allergy and clinical immunology vol. (2021). doi: https://doi.org/10.1016/j.jaci.2021.04.039
Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králíčková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD, Grimbacher B. Therapeutic options for CTLA-4 insufficiency. J Allergy Clin Immunol. 2021 Jun 07; doi: 10.1016/j.jaci.2021.04.039. Epub 2021 Jun 07. PMID: 34111452.
Copy Download .nbib Format: NLM
Serpin Family E Member 1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetic Nephropathy: An Association Study and Meta-Analysis Using a Genetic Model-Free Approach.

Genes

Tziastoudi M, Dardiotis E, Pissas G, Filippidis G, Golfinopoulos S, Siokas V, Tachmitzi SV, Eleftheriadis T, Hadjigeorgiou GM, Tsironi E, Stefanidis I.
PMID: 34946835
Genes (Basel). 2021 Nov 25;12(12). doi: 10.3390/genes12121887.

BACKGROUND: Many lines of evidence highlight the genetic contribution on the development of diabetic nephropathy (DN). One of the studied genes is MATERIALS AND METHODS: A total of 190 patients with DN, 150 T2DM (type 2 diabetes mellitus) patients...

Cite
Tziastoudi M, Dardiotis E, Pissas G, et al. Serpin Family E Member 1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetic Nephropathy: An Association Study and Meta-Analysis Using a Genetic Model-Free Approach. Genes (Basel). 2021;12(12)doi: 10.3390/genes12121887.
Tziastoudi, M., Dardiotis, E., Pissas, G., Filippidis, G., Golfinopoulos, S., Siokas, V., Tachmitzi, S. V., Eleftheriadis, T., Hadjigeorgiou, G. M., Tsironi, E., & Stefanidis, I. (2021). Serpin Family E Member 1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetic Nephropathy: An Association Study and Meta-Analysis Using a Genetic Model-Free Approach. Genes, 12(12), . https://doi.org/10.3390/genes12121887
Tziastoudi, Maria, et al. "Serpin Family E Member 1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetic Nephropathy: An Association Study and Meta-Analysis Using a Genetic Model-Free Approach." Genes vol. 12,12 (2021). doi: https://doi.org/10.3390/genes12121887
Tziastoudi M, Dardiotis E, Pissas G, Filippidis G, Golfinopoulos S, Siokas V, Tachmitzi SV, Eleftheriadis T, Hadjigeorgiou GM, Tsironi E, Stefanidis I. Serpin Family E Member 1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetic Nephropathy: An Association Study and Meta-Analysis Using a Genetic Model-Free Approach. Genes (Basel). 2021 Nov 25;12(12). doi: 10.3390/genes12121887. PMID: 34946835.
Copy Download .nbib Format: NLM
Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache.

Journal of molecular neuroscience : MN

Papasavva M, Vikelis M, Katsarou MS, Siokas V, Dermitzakis E, Papademetriou C, Karakostis K, Lazopoulos G, Dardiotis E, Drakoulis N.
PMID: 34570359
J Mol Neurosci. 2021 Sep 27; doi: 10.1007/s12031-021-01913-8. Epub 2021 Sep 27.

Cluster headache (CH) is a primary headache disorder with a complex genetic background. Several studies indicate a potential link between iron homeostasis and the pathophysiology of primary headaches. The HFE gene encodes for a protein involved in iron metabolism,...

Cite
Papasavva M, Vikelis M, Katsarou MS, et al. Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache. J Mol Neurosci. 2021;doi: 10.1007/s12031-021-01913-8.
Papasavva, M., Vikelis, M., Katsarou, M. S., Siokas, V., Dermitzakis, E., Papademetriou, C., Karakostis, K., Lazopoulos, G., Dardiotis, E., & Drakoulis, N. (2021). Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache. Journal of molecular neuroscience : MN, . https://doi.org/10.1007/s12031-021-01913-8
Papasavva, Maria, et al. "Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache." Journal of molecular neuroscience : MN vol. (2021). doi: https://doi.org/10.1007/s12031-021-01913-8
Papasavva M, Vikelis M, Katsarou MS, Siokas V, Dermitzakis E, Papademetriou C, Karakostis K, Lazopoulos G, Dardiotis E, Drakoulis N. Evidence That HFE H63D Variant Is a Potential Disease Modifier in Cluster Headache. J Mol Neurosci. 2021 Sep 27; doi: 10.1007/s12031-021-01913-8. Epub 2021 Sep 27. PMID: 34570359.
Copy Download .nbib Format: NLM
SmartFFR, a New Functional Index of Coronary Stenosis: Comparison With Invasive FFR Data.

Frontiers in cardiovascular medicine

Siogkas PK, Lakkas L, Sakellarios AI, Rigas G, Kyriakidis S, Stefanou KA, Anagnostopoulos CD, Clemente A, Rocchiccioli S, Pelosi G, Parodi O, Papafaklis MI, Naka KK, Michalis LK, Neglia D, Fotiadis DI.
PMID: 34490377
Front Cardiovasc Med. 2021 Aug 17;8:714471. doi: 10.3389/fcvm.2021.714471. eCollection 2021.

No abstract available.

Cite
Siogkas PK, Lakkas L, Sakellarios AI, et al. SmartFFR, a New Functional Index of Coronary Stenosis: Comparison With Invasive FFR Data. Front Cardiovasc Med. 2021;8:714471doi: 10.3389/fcvm.2021.714471.
Siogkas, P. K., Lakkas, L., Sakellarios, A. I., Rigas, G., Kyriakidis, S., Stefanou, K. A., Anagnostopoulos, C. D., Clemente, A., Rocchiccioli, S., Pelosi, G., Parodi, O., Papafaklis, M. I., Naka, K. K., Michalis, L. K., Neglia, D., & Fotiadis, D. I. (2021). SmartFFR, a New Functional Index of Coronary Stenosis: Comparison With Invasive FFR Data. Frontiers in cardiovascular medicine, 8714471. https://doi.org/10.3389/fcvm.2021.714471
Siogkas, Panagiotis K, et al. "SmartFFR, a New Functional Index of Coronary Stenosis: Comparison With Invasive FFR Data." Frontiers in cardiovascular medicine vol. 8 (2021): 714471. doi: https://doi.org/10.3389/fcvm.2021.714471
Siogkas PK, Lakkas L, Sakellarios AI, Rigas G, Kyriakidis S, Stefanou KA, Anagnostopoulos CD, Clemente A, Rocchiccioli S, Pelosi G, Parodi O, Papafaklis MI, Naka KK, Michalis LK, Neglia D, Fotiadis DI. SmartFFR, a New Functional Index of Coronary Stenosis: Comparison With Invasive FFR Data. Front Cardiovasc Med. 2021 Aug 17;8:714471. doi: 10.3389/fcvm.2021.714471. eCollection 2021. PMID: 34490377; PMCID: PMC8418116.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 87 entries